Molina Healthcare Inc · NYSE:MOH
Molina Healthcare — Q4 2020 Earnings Presentation
7 slides from Molina Healthcare's earnings presentation, Feb 10, 2021
Slide 1: 4Q20 Earnings Supplement
4Q20 Earnings Supplement February 10, 2021 This 4Q20 Earnings Supplement should be read together and in conjunction with the Company’s earnings release dated February 10, 2021.
Slide 2: Cautionary Statement
2 Cautionary Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This presentation and the accompanying oral remarks include forward-looking statements regarding, without limitation, the Company’s strategic position, its projected 2021 financial guidance and fu
Slide 3: 4Q20 Earnings Summary
3 4Q20 GAAP EPS Net Effect of COVID 4Q20 Normalized EPS Adjustments 4Q20 Adjusted EPS $3.29$3.80 $0.56 ($1.07) ($0.51) Normalized 4Q20 earnings continue strong performance and in line with expectations 4Q20 Earnings Summary
Slide 4: 2020 Earnings Summary
4 Net Effect of COVID Adjustments2020 GAAP EPS 2020 Normalized EPS 2020 Adjusted EPS Normalized earnings exceeded guidance of $11.20 - $11.70 per share 2020 Earnings Summary $12.97$2.30 $10.67 $11.23 ($0.56)
Slide 5: 2021 Premium Revenue
5 $18.3B $3.5B >$23.0B Continued execution of our growth strategy leads to 2021 premium revenue of over $23 billion, or 25% growth over 2020 2021 Premium Revenue Net Acquisitions Organic Regulatory Actions $0.8B $0.5B ~4% ~3% ~19% 2020 GAAP Premium Revenue 2021 GAAP Premium Revenue >25%
Slide 6: Growth strategy has similar impacts on all lines of business
6 Growth strategy has similar impacts on all lines of business 2021 Premium Revenue MarketplaceMedicaid2020 GAAP Premium Revenue 2021 GAAP Premium Revenue Medicare $18.3B $3.5B $0.8B $0.4B >$23.0B ~25% ~30% ~25% >25%
Slide 7: 2021 Adjusted EPS
7 2021 Adjusted EPS (~$2.50) (~20%) Temporary Items ~$2.25 ~20% Sustaining Growth 2020 Normalized EPS Core Performance Acquisitions and Share Repurchases Net Effect of COVID Medicare Risk Scores 2021 Adjusted EPS $12.97 $1.25 $1.00 ($1.00) ($1.50) $12.75 Core performance and acquisitions are primary